Phathom Pharmaceuticals, Inc. (PHAT)
8.30
-0.37
(-4.27%)
USD |
NASDAQ |
Sep 10, 12:27
Phathom Pharmaceuticals Market Cap : 664.58M for Sept. 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 09, 2026 | 694.21M |
| September 08, 2026 | 755.06M |
| September 04, 2026 | 760.66M |
| September 03, 2026 | 724.63M |
| September 02, 2026 | 741.45M |
| September 01, 2026 | 751.86M |
| August 31, 2026 | 766.27M |
| August 28, 2026 | 735.04M |
| August 27, 2026 | 715.83M |
| August 26, 2026 | 702.21M |
| August 25, 2026 | 704.62M |
| August 24, 2026 | 693.41M |
| August 21, 2026 | 710.22M |
| August 20, 2026 | 688.60M |
| August 19, 2026 | 746.25M |
| August 18, 2026 | 740.65M |
| August 17, 2026 | 743.05M |
| August 14, 2026 | 767.07M |
| August 13, 2026 | 735.04M |
| August 12, 2026 | 734.24M |
| August 11, 2026 | 681.40M |
| August 10, 2026 | 686.20M |
| August 07, 2026 | 684.60M |
| August 06, 2026 | 671.79M |
| August 05, 2026 | 658.98M |
| Date | Value |
|---|---|
| August 04, 2026 | 676.59M |
| August 03, 2026 | 719.03M |
| July 31, 2026 | 700.61M |
| July 30, 2026 | 723.03M |
| July 29, 2026 | 932.01M |
| July 28, 2026 | 933.62M |
| July 27, 2026 | 956.84M |
| July 24, 2026 | 908.82M |
| July 23, 2026 | 921.53M |
| July 22, 2026 | 929.48M |
| July 21, 2026 | 893.73M |
| July 20, 2026 | 846.06M |
| July 17, 2026 | 869.10M |
| July 16, 2026 | 871.48M |
| July 15, 2026 | 877.84M |
| July 14, 2026 | 876.65M |
| July 13, 2026 | 867.11M |
| July 10, 2026 | 1.002B |
| July 09, 2026 | 966.02M |
| July 08, 2026 | 958.08M |
| July 07, 2026 | 917.56M |
| July 06, 2026 | 904.05M |
| July 02, 2026 | 889.75M |
| July 01, 2026 | 836.93M |
| June 30, 2026 | 861.95M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ANI Pharmaceuticals, Inc. | 1.620B |
| Corcept Therapeutics, Inc. | 12.42B |
| Veru, Inc. | 42.63M |
| Johnson & Johnson | 640.59B |
| Eli Lilly & Co. | 1.058T |
Market Cap Related Metrics
| PS Ratio | 2.710 |
| Price | 8.30 |
| Earnings Yield | -15.36% |